|
Session 6
Opioid Addiction & Pain : Common Features, Receptors & Treatment
Chairs: S. Rudas (AT) |
08.30 |
KEYNOTE SPEAKER: The Opioid Receptor System: Pain and Addiction |
J-K. Zubieta (US) |
09:15 |
Overview on Maintenance Therapy in the EU - Treatment Coverage and Efficacy |
M. Gossop ( UK ) |
09:40 |
Management of Opioid Maintenance Therapy in Austria: Recent Empirical Study |
A. Springer (AT) |
10:05 |
RIOTT: UK Trial of European-Style Supervised Injectable Opiate Maintenance - Bureaucratic and Clinical Challenges and Initial Experiences |
J. Strang (UK) |
10:30 |
Heroin Assisted Treatment: Latest Findings and The International Situation |
W. van den Brink (NL) |
Session 7 - Delegates can choose either session (a) or (b)
|
(a) Compulsory Treatment & Co-morbidity in Substance Dependence
Chair: A. Erfurth (AT) & J. Gölz (DE) |
11:30 |
Treatment Alternatives to Imprisonment - What have we Learnt? Results from a European Study on Quasi-Compulsory Treatment | A. Uchtenhagen (CH) |
11:55 |
Hepatitis C: Treatment in Opioid Dependent Patients | M. Backmund (DE) |
12:20 |
Schizophrenia & Substance Abuse and Dependence |
B. Winklbaur (AT) |
12:45 |
Bipolar Disorder & Substance Abuse and Dependence | I. Maremmani
(EUROPAD, IT) |
(b) New Research Results in Substance Dependence
Chair: S. Haas (DE) & C. Haring (AT) |
11:30 |
Alcohol use and Drug Consumption in Austrian University Students | S. Giacomuzzi (AT) |
11:45 |
Slow-release Morphine (SROM)/Methadone Comparison in Slovenia | A. Kastelic (SL) |
12:00 |
Predicting treatment response with neuroimaging fMRI, Mrspectroscopy and smoking cessation |
C. Schütz (DE) |
12:15 |
Sleep quality improvement with melatonin supplement, among methadone maintenance treatment (MMT) patients abusing benzodiazepines (BDZ) - a double clinical trial | S. Schreiber (IS) |
12:30 |
Strategies of Addiction Policies in Australia |
A. Ritter (AUS) |
13.10 |
Lunch at the Palais Ferstel |
Session 8:
Opioid Dependence: New Medication Development
Chairs: G. Fischer (AT) & M. Potenza (US) |
14:00 |
Australian Trials of Buprenorphine-Naloxone | J. Bell (AUS) |
14:25 |
A Stepped Care Approach Using Buprenorphine-Naloxone: Results of an RCT and New Experiences from Sweden | J. Kakko (SE) |
14:50 |
Switching Patients from Buprenorphine to Buprenorphine-Naloxone: The Icelandic Experience |
V. Rúnarsdóttir (IS) |
15:15 |
Buprenorphine-Naloxone as part of General Medical Practice: A U.S. Experience |
E. Gunderson (US) |
15:40 |
A Randomized, Controlled Comparison of Buprenorphine-Naloxone and Methodone for Opioid Dependence Treatment | J. Kamien (US) |
Session 9 - Delegates can choose either session (a) or (b)
|
(a) Opioid Dependence: S pecial Target Groups & Experiences under the Consideration of Opioid Maintenance
Chairs: A. Ritter (AUS) & C. Schütz (DE) |
|
16:30 |
Trauma & Substance Dependence |
M. Krausz (CAN) |
16:55 |
Substance Dependency and Pregnancy |
L. Finnegan (US) |
17:20 |
Challenges in Clinical Trial Treatment Implementation with Opioid-Dependant Pregnant Women: The MOTHER Study |
A. Arria (US) |
17:45 |
Neonatal Abstinence Syndrome in Neonates of Opioid Maintained Women |
N. Ebner (AT) |
(b) Special Research in Addiction: From Non-substance Related Addiction to Substance Dependence
Chairs: G. B ühringer (DE) & A. Uhl (AT) |
16:30 |
Sensation Seeking and Alexithymia in Different Types of Game: Comparison between Pathological, Regular and Occasional Gamblers |
C. Bonnaire (FR) |
16:55 |
Conducting a Randomised Controlled Trial with Drug Using Prisoners in the UK: the LEEDS Trial |
L. Sheard (UK) |
17:20 |
Electronic Buccal Drug delivery System to Treat Addiction and Chronic Disease |
H. Mell (IS) |
17:45 |
Pregnancy in Women with Opioid Maintenance: Reactions of the Obstetric Staff | M. Langer (AT)
I. Frech (AT) |
18:30 |
Poster Tour & Reception |
18:30 - 19:30 - in German
Short Symposium for Austrian Physicians |
|
